Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Factors affecting post-treatment outcomes in patients with hepatocellular carcinoma

Prognostic Value of Soluble Programmed Death Ligand-1 (sPD-L1) in Hepatocellular Carcinoma

Prognostic factors affecting disease-free survival after hepatic resection for hepatocellular carcinoma in cirrhotic liver

Assessment of Prognostic Accuracy of Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades in Hepatocellular Carcinoma Patients According to Different Treatment Modalities: A P

VALUE OF SERUM ALPHA L FUCOSIDASE LEVEL AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA BEFORE AND AFTER CHEMO-EMBOLIZATION AND RADIO-FREQUENCY, A PROSPECTIVE STUDY

Efficacy of Using Neutrophil to Lymphocyte Ratio and Interleukin 6 as Outcome Predictors of Interventional Treatment of Hepatocellular Carcioma

Prognostic Factors of Liver Resection for Large Hepatocellular Carcinoma in Cirrhotic Patients

Outcomes of hepatocellular carcinoma among patients receiving systemic therapy

Outcome of Transarterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma